loading
Schlusskurs vom Vortag:
$11.63
Offen:
$11.63
24-Stunden-Volumen:
77,190
Relative Volume:
0.59
Marktkapitalisierung:
$96.98M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$10.16
$12.50
52-Wochen-Spanne:
Value
$10.16
$12.50

Retension Pharmaceuticals, Inc. Common Stock Stock (RTSN) Company Profile

Name
Firmenname
Retension Pharmaceuticals, Inc. Common Stock
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
null
Name
Neueste SEC-Einreichungen
Name
RTSN's Discussions on Twitter

Compare RTSN vs VRTX, MRNA, REGN, ARGX, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
RTSN icon
RTSN
Retension Pharmaceuticals, Inc. Common Stock
11.64 96.98M 0 0 0 0.00
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
498.50 126.35B 12.34B 4.34B 3.71B 16.87
MRNA icon
MRNA
Moderna Inc
226.30 90.35B 2.23B -3.19B -1.60B -8.1462
REGN icon
REGN
Regeneron Pharmaceuticals Inc
778.36 80.14B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
818.30 51.46B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
193.52 41.48B 742.00K -1.37B -1.07B -7.0731

Retension Pharmaceuticals, Inc. Common Stock Aktie (RTSN) Neueste Nachrichten

pulisher
Oct 13, 2026

With 402,577 common shares, Retension Pharmaceuticals (RTSN) CEO also holds options priced from $1.43. - Stock Titan

Oct 13, 2026
pulisher
Oct 13, 2026

CEO buys 20,800 shares and receives 255,174 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan

Oct 13, 2026
pulisher
Oct 13, 2026

A director buys at $12 a share and converts preferred stock at Retension Pharmaceuticals (RTSN). - Stock Titan

Oct 13, 2026
pulisher
Oct 13, 2026

Director Pavan Cheruvu receives 5,636 stock options at Retension Pharmaceuticals (RTSN). - Stock Titan

Oct 13, 2026
pulisher
Oct 12, 2026

Total common shares outstanding of RETENSION PHARMACEUTICALS INC – NASDAQ:RTSN - TradingView

Oct 12, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest press releases and corporate news - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) valuation measures and financial statistics - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) analyst ratings, estimates and forecasts - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) cash flow - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock historical prices and data - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) company profile and facts - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 10, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) options chain - Yahoo Finance UK

Oct 10, 2026
pulisher
Oct 09, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 09, 2026
pulisher
Oct 09, 2026

RTSN Interactive Stock Chart | Retension Pharmaceuticals, Inc. Common Stock Stock - Yahoo Finance

Oct 09, 2026
pulisher
Oct 09, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) Analyst Ratings, Estimates & ForecastsYahoo Finance - Yahoo! Finance Canada

Oct 09, 2026
pulisher
Oct 09, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) latest stock news and headlines - Yahoo Finance UK

Oct 09, 2026
pulisher
Oct 09, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) interactive stock chart - Yahoo Finance UK

Oct 09, 2026
pulisher
Oct 08, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock major holders - Yahoo Finance UK

Oct 08, 2026
pulisher
Oct 08, 2026

Retension Pharmaceuticals Announces Pricing of Initial Public Offering - Yahoo! Finance Canada

Oct 08, 2026
pulisher
Oct 08, 2026

Retension Pharmaceuticals, Inc. Common Stock (RTSN) stock price, news, quote and history - Yahoo Finance UK

Oct 08, 2026

Finanzdaten der Retension Pharmaceuticals, Inc. Common Stock-Aktie (RTSN)

Es liegen keine Finanzdaten für Retension Pharmaceuticals, Inc. Common Stock (RTSN) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Retension Pharmaceuticals, Inc. Common Stock-Aktie (RTSN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
BERGER FRANKLIN M
Director
Oct 13 '26
Buy
12.00
10,000
120,000
10,000
$5.465
price down icon 6.10%
$18.00
price down icon 0.83%
$10.29
price down icon 0.19%
$6.80
price down icon 3.13%
$7.40
price up icon 5.71%
$10.23
price down icon 1.54%
Kapitalisierung:     |  Volumen (24h):